New Policies Greatly Impact Skin Sub Reimbursements

Read the FAQs eBook to fully understand these complex, groundbreaking regulations.

In an unprecedented move, on November 14, 2024, all regional Medicare Administrative Carriers (MACs) released identical, final Local Coverage Determinations (LCDs) pertaining to the use of “skin substitutes” for diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs). All Medicare regions will be implementing the same coverage policies when these LCDs become effective on February 12, 2025. The policies standardize highly specific and detailed requirements around the use of Cellular and/or Tissue based products (CTPs), also known as skin substitutes, for DFUs and VLUs.

We recommend you read the LCD(s) yourself, but to help you prepare for these changes, we have summarized the most important details in this FREE eBook.

Complete the form to access the FAQs!